(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MODULADORES DA ATIVIDADE DO COMPLEMENTO

ArquivadaInvention PatentPCT · US2018063719

Application data

Number

112020010916

Type

Invention Patent

Filing

12/04/2018

Publication

11/17/2020

PCT

US2018063719

Progress at the INPI

  1. Filing12/04/18
  2. Publication11/17/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 12/04/2018 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/31/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

RA PHARMACEUTICALS, INC

US

Inventors

A. R. (pessoa física)

US

M. H. (pessoa física)

US

R. F. (pessoa física)

US

Technical data

Priority claims

US

62/594,486 · 12/04/2017

US

62/629,156 · 02/12/2018

US

62/685,314 · 06/15/2018

US

62/769,751 · 11/20/2018

Abstract

A presente invenção refere-se a métodos de tratamento de hemoglobinúria noturna paroxística (PNH) em indivíduos com diferentes exposições a eculizumabe pela administração de R5000. Os métodos incluem métodos de troca de indivíduos do tratamento com eculizumabe para R5000.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

05/31/2022

RPI 2682

Arquivamento - Art. 33 da LPI

#11.1

03/15/2022

RPI 2671

Adição na publicação

#15.35

12/07/2021

RPI 2657

Notificação de entrada na fase nacional - PCT

#1.3

11/17/2020

RPI 2602

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.